ICUI Stock - ICU Medical Inc.

ICUI Stock Chart

ICUI Profile

ICU Medical, Inc., founded in 1984 and headquartered in San Clemente, California, develops, manufactures, and sells medical devices for infusion therapy and critical care applications globally. The company offers a variety of infusion therapy products, including needle-free devices under the MicroClave, MicroClave Clear, and NanoClave brands, as well as the Neutron catheter patency devices and SwabCap and SwabTip disinfecting caps. They also provide Tego hemodialysis connectors, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters, and ChemoClave and ChemoLock closed system transfer devices. Additionally, ICU Medical offers the Diana hazardous drug compounding system for preparing hazardous drugs.

In the realm of IV therapy, ICU Medical supplies diluents like sodium chloride, dextrose, balanced electrolyte solutions, lactated Ringer's, and sterile water. Their irrigation products include sodium chloride and sterile water irrigation, physiologic solutions, Ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. They also provide infusion pumps under the Plum 360 and LifeCare PCA brands, along with ICU Medical MedNet, an IV medication safety software that integrates smart pumps with hospital electronic health records, asset tracking systems, and alarm notification platforms. The company offers related professional services to support these products.

ICU Medical's critical care product line includdes Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems, TDQ and OptiQ cardiac output monitoring catheters, TriOx venous oximetry catheters, Transpac blood pressure transducers, and SafeSet closed blood sampling and conservation systems. The company's products are sold to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities such as outpatient clinics, home healthcare providers, and long-term care facilities.

ICUI Revenue Chart

ICUI Earnings

Analyst Ratings